Zosano Pharma Corporation
ZSAN
ZSAN was delisted on the 10th of June, 2022.
35 hedge funds and large institutions have $13.7M invested in Zosano Pharma Corporation in 2021 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 10 increasing their positions, 8 reducing their positions, and 8 closing their positions.
139% more capital invested
Capital invested by funds: $5.76M → $13.7M (+$7.99M)
25% more repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 8
13% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 8
3% more funds holding
Funds holding: 34 → 35 (+1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$1.57M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$346K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$266K |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$192K |
| 5 |
Barclays
London,
United Kingdom
|
+$179K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Adage Capital Partners
Boston,
Massachusetts
|
-$527K |
| 2 |
TI
Telemetry Investments
New York
|
-$437K |
| 3 |
SCM
Sio Capital Management
New York
|
-$225K |
| 4 |
VF
Virtu Financial
New York
|
-$213K |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$136K |
ZSAN Hedge Fund Activity: Q1 2021 in Review
35 of the 5,696 institutional investors tracked by Wall St. Rank reported a position in Zosano Pharma Corporation (ZSAN) for Q1 2021, worth a combined $13.7M — up 139% from $5.76M a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new ZSAN positions and 8 closed out — a net gain of 1 holder — while 10 added to existing stakes and 8 trimmed.
The largest buyer was BlackRock, adding an estimated $1.57M. The largest seller was Adage Capital Partners, exiting entirely with an estimated $527K sold.
- 35 institutional investors held Zosano Pharma Corporation (ZSAN) as of Q1 2021, up from 34 in Q4 2020.
- Funds reported $13.7M of Zosano Pharma Corporation stock for Q1 2021, up 139% quarter-over-quarter.
- 9 funds opened new Zosano Pharma Corporation positions in Q1 2021 and 8 closed out, a net change of +1 holder.
- The largest Zosano Pharma Corporation buyer in Q1 2021 was BlackRock, an estimated $1.57M added.
- The largest Zosano Pharma Corporation seller in Q1 2021 was Adage Capital Partners, an estimated $527K sold.
Based on aggregated 13F filings for Q1 2021.